Sylvia C. Stanat

Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised Patients

Alejo Erice, Sunwen Chou, Karen K. Biron et al. · New England Journal of Medicine · 1989 · 408 citations

Life Sciences, Infectious Diseases, Microbiology +14

Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole <scp>l</scp> -Riboside with a Unique Mode of Action

Karen K. Biron, Stanley C. Chamberlain, Steven S. Good et al. · Antimicrobial Agents and Chemotherapy · 2002 · 364 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Analysis Of The Ul97 Phosphotransferase Coding Sequence In Clinical Cytomegalovirus Isolates And Identification Of Mutations Conferring Ganciclovir Resistance

Szu‐Yi Chou, Alejo Erice, M. Colin Jordan et al. · The Journal of Infectious Diseases · 1995 · 243 citations

Life Sciences, Infectious Diseases, Microbiology +17

Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus.

Karen K. Biron, Sylvia C. Stanat, J B Sorrell et al. · Proceedings of the National Academy of Sciences · 1985 · 238 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +15

Inhibition of Human Cytomegalovirus DNA Maturation by a Benzimidazole Ribonucleoside Is Mediated through the UL89 Gene Product

Mark Underwood, Sylvia C. Stanat, Mary Lou Hemphill et al. · Journal of Virology · 1998 · 193 citations · Full text

Life Sciences, Microbiology, Molecular Biology +15